Alpha Signal Monitor - Daily Market Briefing | March 20, 2026
Daily Market Research Report
March 20, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETF Outlook (GLD, IAU, BAR) — Institutional Consensus as of March 20, 2026
Trading Idea: Buy Rationale (TL;DR): Most top houses now see gold ending 2026 in the $4,400–$5,400/oz zone (with upside scenarios higher), underpinned by persistent central‑bank accumulation, renewed ETF inflows as policy eases, and elevated geopolitical and fiscal risk. While Citi remains a bearish outlier (calls for $2,500–$2,700 by 2H26), the modal view argues for staying long physical‑backed ETFs like GLD/IAU/BAR and adding on volatility-driven dips. (marketscreener.com)
2026 opens with gold near record territory after a 2025 surge. Consensus drivers cited by banks include declining real yields as the Fed eases, structurally rising official‑sector demand, and renewed private/ETF allocation amid policy uncertainty and fiscal strain. UBS forecasts 2026 central‑bank purchases near 950t and ETF inflows ~825t; JPM’s base case ties further gains to a Fed cutting cycle; Goldman cites private‑sector and EM reserve diversification as the latest leg. (ubs.com)
Key Drivers - Policy easing and lower real yields improve the relative appeal of non‑yielding gold versus cash/bonds. - Central‑bank diversification (notably EM) continues to add a structural bid. - ETF inflows have resumed as institutions rebalance toward real assets. - Mine supply remains inelastic; cost inflation and permitting constraints limit rapid output growth. - Persistent geopolitical uncertainty and U.S. fiscal concerns sustain safe‑haven demand.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | $5,400/oz (end‑2026) | Raised end‑2026 gold forecast to $5,400/oz (from $4,900), citing stronger private‑sector allocation and ongoing EM central‑bank diversification; expects ETF holdings to rise as the Fed cuts in 2026. | 2026-01-22 | (marketscreener.com) |
| Morgan Stanley | - | $4,400/oz (2026) | Revised 2026 forecast up to $4,400 on a weaker USD, continued central‑bank buying and ETF inflows; notes potential demand destruction at very high prices. | 2025-10-22 | (morganstanley.com) |
| JP Morgan | Highest conviction long | $5,055/oz (Q4‑2026); multi‑year target $6,000 by 2028 | Base case assumes ~566t/quarter of combined investor and central‑bank buying in 2026; sees further upside as the Fed enters a rate‑cut cycle, with stagflation anxiety and debasement hedging supporting gold. | 2025-10-24 | (mining.com) |
| Bank of America | - | Up to $6,000/oz by Spring 2026; prior 2026 average guide ~ $4,538/oz | BofA’s precious‑metals team sees scope for $6,000/oz by Spring 2026; earlier guidance called for a 2026 average near $4,538 with a high around $5,000 as macro supports persist. | 2026-01-23 | (kitco.com) |
| Citigroup | Underweight (bearish) | $2,500–$2,700/oz by 2H‑2026 (call made mid‑2025) | Citi’s Max Layton told BNN Bloomberg their base case is for gold to fall back below $3,000 and into the $2,500–$2,700 range by the second half of 2026; Citi’s 4Q25 deck discussed near‑term strength but remained cautious beyond 6–12 months. | 2025-06-19 | (bnnbloomberg.ca) |
| UBS | - | $5,000/oz in 1–3Q26, moderating to $4,800 by Dec‑2026 (upside $5,400) | UBS CIO’s central scenario targets $4,800 by year‑end 2026, with a path to ~$5,000 earlier in the year; drivers include lower real yields, fiscal stress, and robust official‑sector and ETF demand (forecast 950t CB buying; 825t ETF inflows). Downside risks include a hawkish Fed pivot or large ETF outflows. | 2026-01-29 | (ubs.com) |
| HSBC | - | $5,000/oz in 1H‑2026; 2026 avg ~$4,587; year‑end ~$4,450 (range $3,950–$5,050) | HSBC (James Steel) sees potential to $5,000 in 1H26 but trimmed the 2026 average to ~$4,587 and flagged a volatile trading range with risk of correction later in the year. | 2026-01-08 | (kitco.com) |
| Deutsche Bank | - | $4,500/oz (end‑2026) | DB’s Capital Markets Outlook 2026 pegs year‑end 2026 gold at $4,500/oz, citing continued central‑bank demand and use as a hedge alongside AI‑led equity exposure. | 2025-11-26 | (db.com) |
Risk Considerations - Stronger‑than‑expected real yields or a firmer USD could cap or reverse gains. - A sharp drop in geopolitical risk or decisive policy stabilization could unwind part of the risk premium. - ETF outflows or profit‑taking following parabolic moves could force deeper corrections (HSBC flags elevated 2026 volatility; UBS highlights downside if the Fed surprises hawkishly). (kitco.com) - High prices can destroy price‑sensitive demand (e.g., jewelry), muting upside. - Citi’s bearish case (sub‑$3,000 by 2H26) warns of downside if investment demand fades. (bnnbloomberg.ca)
Implementation: use low‑cost, physically backed ETFs (GLD/IAU/BAR). Given 2026’s heightened volatility and a broadly bullish but non‑linear institutional path, scale in on pullbacks, size positions prudently, and monitor real yields, ETF flow trends, and policy/geopolitical headlines closely.
Stock Ratings — Street Price Targets and Ratings (GS · MS · JPM · BAC · C · WFC) — As of March 20, 2026
Below are the latest publicly reported target prices, ratings, and update dates for the requested U.S. tech stocks from the six specified institutions. Dates reflect the most recent note we could verify in public sources. Currency is USD unless noted.
AAPL - Apple Inc.
Broad Buy/Overweight skew across the six; multiple late-2025/Jan-2026 target lifts.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $320 | 2025-10-31 | - | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-apple-stock-price-target-to-320-on-strong-demand-93CH-4322393 |
| Morgan Stanley | Overweight | $315 | 2025-12-17 | - | https://appleinsider.com/articles/25/12/17/morgan-stanley-raises-apple-stock-target-to-315-citing-incredible-2026 |
| JP Morgan | Overweight | $315 | 2026-01-26 | - | https://www.investing.com/news/analyst-ratings/apple-stock-price-target-raised-to-315-from-305-at-jpmorgan-93CH-4465277 |
| Bank of America | Buy | $320 | 2025-10-29 | - | https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html |
| Citigroup | Buy | $330 | 2025-12-09 | - | https://www.investing.com/news/stock-market-news/citi-raises-apple-price-target-on-firmer-upgrade-cycle-iphone-17-strength-4398652 |
| Wells Fargo | Overweight | $300 | 2025-12-29 | - | https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681 |
Consensus View - Rating: Buy, Target Price: $316.67 - Mean of the six listed targets; sentiment strongly positive.
MSFT - Microsoft Corp.
Targets reset around Jan 29, 2026; GS and JPM trimmed on capex/AI spend while others stay bullish.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $600 | 2026-01-29 | Cut from $655. | https://uk.investing.com/news/analyst-ratings/goldman-sachs-lowers-microsoft-stock-price-target-to-600-on-capex-concerns-93CH-4476288 |
| Morgan Stanley | Overweight | $650 | 2026-01-14 | - | https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158 |
| JP Morgan | Overweight | $550 | 2026-01-29 | Trim from $575. | https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-issues-pessimistic-forecast-for-microsoft-nasdaqmsft-stock-price-2026-01-29/ |
| Bank of America | Buy | $520 | 2026-01-27 | Lowered from $640 ahead of earnings. | https://www.marketbeat.com/instant-alerts/bank-of-america-cuts-microsoft-nasdaqmsft-price-target-to-52000-2026-01-26/ |
| Citigroup | Buy | $635 | 2026-01-29 | Cut from $660 post-print. | https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/ |
| Wells Fargo | Overweight | $630 | 2026-01-22 | Cut from $665. | https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-price-target-lowered-to-63000-at-wells-fargo-company-2026-01-22/ |
Consensus View - Rating: Buy, Target Price: $597.50 - Mean of the six listed targets; constructive view despite higher AI capex.
GOOGL - Alphabet Inc.
Most banks raised targets into Jan 2026; WFC at Equal-Weight with a higher PT.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $375 | 2026-01-13 | - | https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news |
| Morgan Stanley | Overweight | $205 | 2025-07-21 | - | https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-4143076 |
| JP Morgan | Overweight | $300 | 2025-10-27 | - | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660 |
| Bank of America | Buy | $370 | 2026-01-13 | - | https://www.gurufocus.com/news/4108093/googl-b-of-a-securities-raises-price-target-to-370-googl-stock-news |
| Citigroup | Buy | $203 | 2025-06-24 | - | https://www.gurufocus.com/news/2943031/googl-citigroup-raises-price-target-for-alphabet-to-203-googl-stock-news |
| Wells Fargo | Equal-Weight | $350 | 2026-01-12 | - | https://www.gurufocus.com/news/4106624/googl-wells-fargo-raises-alphabets-target-price-to-350-googl-stock-news |
Consensus View - Rating: Buy, Target Price: $300.50 - Mean of the six listed targets; overall positive with one Neutral/Equal-Weight.
AMZN - Amazon.com Inc.
Broad Buy bias; BAC trimmed PT to $286 into the late-Jan 2026 print.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-10-03 | - | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016 |
| Morgan Stanley | Overweight | $300 | - | Raised from $250 ahead of 2H25; date not clearly stated in public recap. | https://www.barrons.com/articles/amazon-stock-price-target-earnings-b8814a52 |
| JP Morgan | Overweight | $255 | 2025-07-11 | - | https://www.gurufocus.com/news/2972940/jp-morgan-raises-price-target-for-amazon-amzn-to-255--amzn-stock-news |
| Bank of America | Buy | $286 | 2026-01-27 | Trimmed from $303 ahead of results. | https://www.marketbeat.com/instant-alerts/amazoncom-nasdaqamzn-given-new-28600-price-target-at-bank-of-america-2026-01-27/ |
| Citigroup | Buy | $245 | - | Latest explicit Citi AMZN PT we could validate publicly was in 2025. | https://www.investing.com/news/analyst-ratings/jpmorgan-cuts-amazon-stock-price-target-keeps-overweight-93CH-3551490 |
| Wells Fargo | Overweight | $295 | 2025-12-02 | - | https://www.gurufocus.com/news/3230110/amazoncom-amzn-wells-fargo-raises-price-target-to-295-amzn-stock-news |
Consensus View - Rating: Buy, Target Price: $276.00 - Mean of the six listed targets; constructive on AWS and retail mix.
NVDA - NVIDIA Corp.
Targets generally clustered in the $200–265 range across coverage into late‑2025.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $240 | 2025-11-20 | Raised around Nov. 2025; multiple follow-up previews reiterated Buy. | https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html |
| Morgan Stanley | Overweight | $200 | - | Late‑2025 updates raised PT multiple times; latest widely cited level ≈$200 in public summaries. | https://economictimes.indiatimes.com/news/international/us/nvidia-stock-price-target-2025-morgan-stanley-just-boosted-nvidias-target-heres-why-blackwell-chips-are-game-changers/articleshow/123044159.cms |
| JP Morgan | Overweight | $215 | 2025-08-30 | - | https://www.americanbankingnews.com/2025/08/30/jpmorgan-chase-co-increases-nvidia-nasdaqnvda-price-target-to-215-00.html |
| Bank of America | Buy | $235 | 2025-08-28 | - | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-nvidia-stock-price-target-to-235-on-ai-dominance-93CH-4214327 |
| Citigroup | Buy | $220 | 2025-11-10 | - | https://www.gurufocus.com/news/3200075/citigroup-raises-nvidia-nvda-price-target-to-220-while-maintaining-buy-rating-nvda-stock-news |
| Wells Fargo | Overweight | $265 | 2025-11-14 | - | https://www.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4372326 |
Consensus View - Rating: Buy, Target Price: $229.17 - Mean of the six listed targets; positive AI data‑center thesis remains central.
META - Meta Platforms Inc.
After strong Q4’25 results and an elevated 2026 capex guide, most banks kept/raised very high PTs.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $835 | 2026-01-29 | Raised from $815. | https://uk.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-835-from-815-at-goldman-sachs-93CH-4476290 |
| Morgan Stanley | Overweight | $750 | 2025-12-11 | - | https://uk.finance.yahoo.com/news/morgan-stanley-sees-three-key-145806104.html |
| JP Morgan | Overweight | $825 | 2026-01-29 | - | https://uk.investing.com/news/analyst-ratings/jpmorgan-raises-meta-stock-price-target-to-825-on-strong-revenue-outlook-93CH-4477156 |
| Bank of America | Buy | $885 | 2026-01-29 | Raised from $810 post‑earnings. | https://www.investing.com/news/analyst-ratings/meta-stock-price-target-raised-to-885-from-810-at-bofa-securities-93CH-4472310 |
| Citigroup | Buy | $753 | 2025-01-24 | - | https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-meta-stock-reiterates-753-price-target-93CH-3830332 |
| Wells Fargo | - | - | - | No recent, on-record Wells Fargo META PT found in public sources. | - |
Consensus View - Rating: Buy, Target Price: $809.60 - Average of five explicit targets (WFC not available).
TSLA - Tesla Inc.
Mixed-to-cautious skew into 2026 with multiple Neutral/Underweight calls as the story pivots to AI/robotics.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Neutral | $405 | 2026-01-29 | Lowered from $420. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-tesla-stock-price-target-to-405-on-ai-focus-shift-93CH-4472132 |
| Morgan Stanley | Equal-weight | $425 | 2025-12-16 | - | https://uk.finance.yahoo.com/news/tesla-stock-focus-morgan-stanley-161721528.html |
| JP Morgan | Underweight | $145 | 2026-01-30 | Cut from $150. | https://www.marketbeat.com/instant-alerts/tesla-nasdaqtsla-price-target-cut-to-14500-by-analysts-at-jpmorgan-chase-co-2026-01-30/ |
| Bank of America | Neutral | $305 | 2025-04-23 | - | https://www.investing.com/news/analyst-ratings/bofa-maintains-tesla-stock-rating-305-price-target-postearnings-93CH-3997931 |
| Citigroup | Neutral | $180 | - | Latest public Citi TSLA PT in 2025 per TheFly summary. | https://www.thefly.com/permalink.aspx?id=3931866 |
| Wells Fargo | Underweight | $125 | 2026-01-29 | Cut from $130. | https://www.marketbeat.com/instant-alerts/wells-fargo-company-has-lowered-expectations-for-tesla-nasdaqtsla-stock-price-2026-01-29/ |
Consensus View - Rating: Neutral, Target Price: $264.17 - Mean of the six listed targets; ratings skew Neutral/Underweight.
AVGO - Broadcom Inc.
AI custom silicon/networking momentum lifted late‑2025 targets; some banks’ explicit PTs not publicly posted.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $435 | 2025-11-26 | - | https://www.gurufocus.com/news/3225513/goldman-sachs-raises-price-target-on-broadcom-avgo-to-435-reaffirms-buy-rating-avgo-stock-news |
| Morgan Stanley | Overweight | - | - | MS called AVGO a top AI pick and revised estimates upward; latest explicit PT not available in public recap. | https://www.investing.com/news/analyst-ratings/morgan-stanley-views-broadcom-shares-as-a-top-ai-stock-pick-revises-target-upward-93CH-3772000 |
| JP Morgan | Overweight | $400 | 2025-09-05 | - | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521 |
| Bank of America | Buy | $500 | 2025-12-12 | - | https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225 |
| Citigroup | - | - | - | No recent, on-record Citi AVGO PT found in public sources. | - |
| Wells Fargo | - | - | - | No recent, on-record WFC AVGO PT found in public sources. | - |
Consensus View - Rating: Buy, Target Price: $445.00 - Average of available GS/JPM/BAC targets; strong AI exposure cited across notes.
TSM - Taiwan Semiconductor Manufacturing Co. Ltd. (ADR)
Most coverage quotes targets in NT$; ADR approximations provided where available.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Conviction Buy | NT$2,600 (≈ $466 ADR) | 2026-01-15 | - | https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt2600-by-goldman-sachs-on-ai-growth-93CH-4450325 |
| Morgan Stanley | Overweight | NT$2,088 | 2026-01-16 | Top pick; raised after Q4 beat and higher capex. | https://www.investing.com/news/stock-market-news/tsmc-stock-target-raised-at-morgan-stanley-on-margins-strength-4451800 |
| JP Morgan | Overweight | NT$2,100 | 2026-01-07 | - | https://m.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161?ampMode=1 |
| Bank of America | Buy | NT$1,600 (≈ $330 ADR) | 2025-10-07 | - | https://www.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-4275321 |
| Citigroup | Buy | NT$1,050 | 2025-04-10 | - | https://www.investing.com/news/analyst-ratings/citi-cuts-tsmc-stock-price-target-to-twd1050-keeps-buy-rating-3978424 |
| Wells Fargo | - | - | - | No recent, on-record WFC TSMC PT found in public sources. | - |
Consensus View - Rating: Buy - Consensus rating Buy; target not shown due to mixed currencies (NT$ vs ADR USD).
Highlights
- Most bullish setups: META, MSFT, and AMZN show Buy/Overweight consensus and high absolute targets into early 2026.
- Apple (AAPL) saw multiple late‑2025/Jan‑2026 raises (GS $320; MS $315; JPM $315).
- Tesla (TSLA) skews Neutral/Underweight across the six, with JPM $145 and WFC $125 anchoring the low end.
- NVIDIA (NVDA) targets cluster in the $200–265 range; WFC sits high at $265.
- For TSMC, quoted targets are primarily in NT$, with ADR approximations noted; consensus rating is Buy but target omitted due to currency mix.
Notes: (1) When an explicit, recent bank price target was not publicly verifiable, fields are set to null with a clarifying note. (2) Consensus target price is a simple mean of available numeric targets shown above; consensus rating reflects the modal tilt (Buy/Overweight ≈ Buy; Equal-weight/Neutral ≈ Hold; Underweight ≈ Sell). If you’d like these consolidated in a CSV or with currency normalization (e.g., TSM NT$ → USD ADR), I can provide that as a follow‑up.
IPO Calendar
Timeframe: March 20, 2026 to April 20, 2026 (U.S. equity markets)
Pipeline momentum into late March/April skews toward healthcare and resources, with one biotech set to price the week of March 23 and multiple resources-focused listings in the queue (including a direct listing). REIT spin-offs continue as sponsors seek to surface value and recycle capital. SPAC issuance remains present, though timing is fluid pending SEC effectiveness. Macro-wise, exchanges and listings desks flag improving 2026 conditions versus 2025, but individual deal timing can still shift based on markets and the SEC review cadence.
Salspera, Inc. (TKVA)
- Expected listing date: Week of March 23, 2026 (pricing target)
- Price range: $14.00–$16.00
- Shares offered: 5,666,666 primary shares (+ up to 850,000 over-allotment)
- Exchange: Nasdaq
- Lead underwriters: Kingswood Capital Partners, LLC
- Business summary: Clinical‑stage immuno‑oncology company developing live biotherapeutics for solid tumors. Lead candidate Saltikva (engineered Salmonella‑IL‑2) completed Phase 2 in metastatic pancreatic cancer; IPO proceeds primarily fund Phase 3 and Phase 2 programs in osteosarcoma and metastatic colorectal cancer. (sec.gov)
- Notes: Issuer free writing prospectus indicates an expected pricing window in the week of March 23, 2026; actual pricing/listing remains subject to SEC effectiveness and market conditions. 180‑day lock‑up for officers/directors noted. (sec.gov)
- Sources: SEC S-1/A (Mar 10, 2026), SEC Issuer Free Writing Prospectus (Mar 4, 2026), FierceBiotech coverage (Mar 11, 2026)
The Metals Royalty Company Inc. (TMCR)
- Shares offered: Up to 55,061,113 common shares registered for resale in connection with a direct listing
- Exchange: Nasdaq Global Market
- Business summary: Royalty/streaming company focused on U.S. critical minerals and re‑industrialization. Portfolio anchored by a 2.0% gross overriding royalty on the NORI polymetallic deposit associated with TMC the metals company. Listing via direct listing (no primary capital raise). (nasdaq.com)
- Notes: Company filed a Form F‑1 for a proposed direct listing; listing expected after SEC review and effectiveness. No IPO price will be set; timing TBD. (sec.gov)
- Sources: Nasdaq press release (Mar 2, 2026), SEC Ex‑5.1 to Form F‑1 (Feb 27, 2026)
Guardian Metal Resources PLC (GMTL)
- Exchange: NYSE
- Lead underwriters: BMO Capital Markets Corp.
- Business summary: U.S.‑focused exploration‑stage critical minerals company (primary focus: tungsten) with a portfolio of Nevada projects including Pilot Mountain and Tempiute; aims to onshore strategic minerals supply. Plans to list U.S. ADSs on the NYSE under GMTL. (sec.gov)
- Notes: Filed a registration statement (Form F‑1) for a U.S. IPO of ADSs on Feb 27, 2026; the company states share count and price range are not yet determined and the offering is subject to market and regulatory conditions. (morningstar.com)
- Sources: SEC Form F‑1 (public filing), Morningstar/Alliance News coverage of filing (Feb 27, 2026)
Janus Living, Inc. (JAN)
- Exchange: NYSE
- Lead underwriters: BofA Securities, J.P. Morgan
- Business summary: Pure‑play senior housing REIT formed by Healthpeak Properties to own, acquire and develop senior housing under a RIDEA structure; initial portfolio contemplated at 34 communities (10,422 units). Healthpeak intends to retain control post‑IPO. (s202.q4cdn.com)
- Notes: Public Form S‑11 filed Feb 27, 2026; number of shares, price range and timing not yet set. Healthpeak guides to a first‑half‑2026 IPO, subject to SEC review and market conditions. (ir.healthpeak.com)
- Sources: Healthpeak IR press release (Feb 27, 2026), Healthpeak investor presentation (Feb 27, 2026)
Blue Water Acquisition Corp. IV (SPAC) (BWIV.U)
- Price range: Units customarily priced at $10.00 (size: $125 million)
- Exchange: NYSE
- Lead underwriters: BTIG, LLC (sole book‑running manager)
- Business summary: Blank‑check company targeting biotechnology, healthcare and technology sectors; proceeds held in trust pending a future business combination. (prnewswire.com)
- Notes: S‑1 publicly filed Dec 5, 2025; offering timing subject to SEC effectiveness and market conditions. Unit count/pricing mechanics typical for SPACs; confirm final terms at pricing. (prnewswire.com)
- Sources: Company press release via PR Newswire (Dec 5, 2025)
Future Money Acquisition Corporation (SPAC) (FMACU)
- Price range: $10.00 per unit
- Shares offered: 10.0 million units (proposed)
- Exchange: Nasdaq
- Business summary: Blank‑check company targeting AI, Web3 and intelligent manufacturing businesses. (renaissancecapital.com)
- Notes: Most recent S‑1/A filed Mar 6, 2026; offering size and unit count shown in filed terms. Underwriter disclosure not final in exhibits‑only amendment; see profile for context. Listing date TBD pending SEC effectiveness. (sec.gov)
- Sources: SEC S‑1/A filing index (Mar 6, 2026), Renaissance Capital profile (filed terms)
Dates and terms are inherently subject to change until pricing and exchange approval. Direct listings (e.g., TMCR) do not set an IPO price and may list only after SEC effectiveness. SPAC deals (BWIV.U, FMACU) can shift quickly based on market windows and SEC review; confirm final prospectus at pricing. The timeframe here covers March 20, 2026 to April 20, 2026; some expected offerings may price after this window if reviews extend.
Sources
- Stock Ratings: https://appleinsider.com/articles/25/12/17/morgan-stanley-raises-apple-stock-target-to-315-citing-incredible-2026
>, <https://economictimes.indiatimes.com/news/international/us/nvidia-stock-price-target-2025-morgan-stanley-just-boosted-nvidias-target-heres-why-blackwell-chips-are-game-changers/articleshow/123044159.cms, https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html>, <https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html, https://m.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161?ampMode=1>, <https://uk.finance.yahoo.com/news/morgan-stanley-sees-three-key-145806104.html, https://uk.finance.yahoo.com/news/tesla-stock-focus-morgan-stanley-161721528.html>, <https://uk.investing.com/news/analyst-ratings/goldman-sachs-lowers-microsoft-stock-price-target-to-600-on-capex-concerns-93CH-4476288, https://uk.investing.com/news/analyst-ratings/jpmorgan-raises-meta-stock-price-target-to-825-on-strong-revenue-outlook-93CH-4477156>, <https://uk.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-835-from-815-at-goldman-sachs-93CH-4476290, https://www.americanbankingnews.com/2025/08/30/jpmorgan-chase-co-increases-nvidia-nasdaqnvda-price-target-to-215-00.html>, <https://www.barrons.com/articles/amazon-stock-price-target-earnings-b8814a52, https://www.gurufocus.com/news/2943031/googl-citigroup-raises-price-target-for-alphabet-to-203-googl-stock-news>, <https://www.gurufocus.com/news/2972940/jp-morgan-raises-price-target-for-amazon-amzn-to-255--amzn-stock-news, https://www.gurufocus.com/news/3200075/citigroup-raises-nvidia-nvda-price-target-to-220-while-maintaining-buy-rating-nvda-stock-news>, <https://www.gurufocus.com/news/3225513/goldman-sachs-raises-price-target-on-broadcom-avgo-to-435-reaffirms-buy-rating-avgo-stock-news, https://www.gurufocus.com/news/3230110/amazoncom-amzn-wells-fargo-raises-price-target-to-295-amzn-stock-news>, <https://www.gurufocus.com/news/4106624/googl-wells-fargo-raises-alphabets-target-price-to-350-googl-stock-news, https://www.gurufocus.com/news/4108093/googl-b-of-a-securities-raises-price-target-to-370-googl-stock-news>, <https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news, https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-205-from-185-at-morgan-stanley-4143076>, <https://www.investing.com/news/analyst-ratings/apple-stock-price-target-raised-to-315-from-305-at-jpmorgan-93CH-4465277, https://www.investing.com/news/analyst-ratings/bofa-maintains-tesla-stock-rating-305-price-target-postearnings-93CH-3997931>, <https://www.investing.com/news/analyst-ratings/bofa-securities-raises-nvidia-stock-price-target-to-235-on-ai-dominance-93CH-4214327, https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225>, <https://www.investing.com/news/analyst-ratings/citi-cuts-tsmc-stock-price-target-to-twd1050-keeps-buy-rating-3978424, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-meta-stock-reiterates-753-price-target-93CH-3830332>, <https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-tesla-stock-price-target-to-405-on-ai-focus-shift-93CH-4472132, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016>, <https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-apple-stock-price-target-to-320-on-strong-demand-93CH-4322393, https://www.investing.com/news/analyst-ratings/jpmorgan-cuts-amazon-stock-price-target-keeps-overweight-93CH-3551490>, <https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521>, <https://www.investing.com/news/analyst-ratings/meta-stock-price-target-raised-to-885-from-810-at-bofa-securities-93CH-4472310, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158>, <https://www.investing.com/news/analyst-ratings/morgan-stanley-views-broadcom-shares-as-a-top-ai-stock-pick-revises-target-upward-93CH-3772000, https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt2600-by-goldman-sachs-on-ai-growth-93CH-4450325>, <https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681, https://www.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4372326>, <https://www.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-4275321, https://www.investing.com/news/stock-market-news/citi-raises-apple-price-target-on-firmer-upgrade-cycle-iphone-17-strength-4398652>, <https://www.investing.com/news/stock-market-news/tsmc-stock-target-raised-at-morgan-stanley-on-margins-strength-4451800, https://www.marketbeat.com/instant-alerts/amazoncom-nasdaqamzn-given-new-28600-price-target-at-bank-of-america-2026-01-27/>, <https://www.marketbeat.com/instant-alerts/bank-of-america-cuts-microsoft-nasdaqmsft-price-target-to-52000-2026-01-26/, https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-issues-pessimistic-forecast-for-microsoft-nasdaqmsft-stock-price-2026-01-29/>, <https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/, https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-price-target-lowered-to-63000-at-wells-fargo-company-2026-01-22/>, <https://www.marketbeat.com/instant-alerts/tesla-nasdaqtsla-price-target-cut-to-14500-by-analysts-at-jpmorgan-chase-co-2026-01-30/, https://www.marketbeat.com/instant-alerts/wells-fargo-company-has-lowered-expectations-for-tesla-nasdaqtsla-stock-price-2026-01-29/>, <https://www.thefly.com/permalink.aspx?id=3931866 - IPO Calendar: https://ir.healthpeak.com/news/news-details/2026/Healthpeak-Properties-Inc--Announces-Public-Filing-of-Registration-Statement-with-the-SEC-for-Janus-Living-Inc-/default.aspx, https://s202.q4cdn.com/584270836/files/doc_presentations/2026/Feb/27/Healthpeak-February-27-2026-Investor-Presentation_vF.pdf?utm_source=openai, https://www.morningstar.com/news/alliance-news/1772188264512514600/guardian-metal-files-registration-with-sec-to-list-in-new-york?utm_source=openai, https://www.nasdaq.com/press-release/metals-royalty-company-inc-announces-public-filing-registration-statement-proposed, https://www.prnewswire.com/news-releases/blue-water-acquisition-corp-iv-sponsored-by-serial-entrepreneur-joseph-hernandez-files-125million-ipo-registration-statement-with-the-us-securities-and-exchange-commission-302634470.html, https://www.renaissancecapital.com/Profile/FMACU/Future-Money-Acq/IPO, https://www.sec.gov/Archives/edgar/data/0002039972/000110465926011636/filename1.htm, https://www.sec.gov/Archives/edgar/data/2084032/000121390026023531/ea0279573-fwp_salspera.htm, https://www.sec.gov/Archives/edgar/data/2084032/000121390026025748/ea0256863-08.htm, https://www.sec.gov/Archives/edgar/data/2087398/000110465926021062/tm2526563d11_ex5-1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2099232/000149315226009237/0001493152-26-009237-index.htm
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-03-20 at 11:33 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI